1. Market Research
  2. > Cancer Industry

Prostate Cancer Industry, June 2016 Market Reports from Top Publishers

You might be interested in: Molecular Diagnostic, Diagnostics, Cancer, Therapy, Hormone, Biopsy, Cancer Diagnostic, Magnetic Resonance Imaging, Genetic, Healthcare, Biomarker, Oncology, Vaccine, Blood Disease, Carotenoid, Lung Cancer, Medical Robotics, Nuclear Imaging Equipment, Pharmaceutical, Transdermal Delivery.


 
1-10 of 85 reports for Prostate Cancer

Purchase Reports From Reputable Market Research Publishers

Benign Prostatic Hyperplasia - Pipeline Review, H1 2016

Benign Prostatic Hyperplasia - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • May 2016
  • by Global Markets Direct

Benign Prostatic Hyperplasia - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Benign Prostatic Hyperplasia - Pipeline Review, H1 2016’, provides an overview of the Benign Prostatic Hyperplasia ...

Global Prostate Cancer Partnering 2010 to 2016

Global Prostate Cancer Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • June 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. - Trends ...

Treatment of Prostate Cancer - Patent Overview in the years 2011 - 2016

Treatment of Prostate Cancer - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • June 2016
  • by Mordor Intelligence LLP

Prostate cancer is cancer that starts in the prostate gland. The prostate is a small, walnut-sized structure that makes up part of a man's reproductive system. It wraps around the urethra. Prostate cance ...

Circulating Tumor Cells Market Analysis By Technology (Filtration, Centrifugation, Immunological & Immunomagnetic, Optical, Molecular, Tumor Cell Enrichment & Detection), By Application (Prostate Cancer, Breast Cancer, Colorectal Cancer) and Segment Forec

Circulating Tumor Cells Market Analysis By Technology (Filtration, Centrifugation, Immunological & Immunomagnetic, Optical, Molecular, Tumor Cell Enrichment & Detection), By Application (Prostate Cancer, Breast Cancer, Colorectal Cancer) and Segment Forec

  • $ 4 700
  • Industry report
  • May 2016
  • by Grand View Research

Global circulating tumor cells market is expected to reach USD 2.28 billion by 2020. Growing prevalence of cancer has heightened the need for effective and early diagnosis. Circulating tumor cells cate ...

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • May 2016
  • by Global Markets Direct

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, ...

Global Prostate Cancer Therapeutics Industry

Global Prostate Cancer Therapeutics Industry

  • $ 4 500
  • Industry report
  • May 2016
  • by Global Industry Analysts

This report analyzes the worldwide markets for Prostate Cancer Therapeutics in US$ Million by the following Segments: Hormone Therapy, and Other Therapies. The report provides separate comprehensive analytics ...

The Prostate Cancer Market 2016-2026: Increasing Incidence and Promising New Therapies to Drive Market Growth

The Prostate Cancer Market 2016-2026: Increasing Incidence and Promising New Therapies to Drive Market Growth

  • $ 2 807
  • Industry report
  • April 2016
  • by Visiongain

Report Details What can be expected from the prostate cancer market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, ...

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • April 2016
  • by Global Markets Direct

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hormone Refractory (Castration Resistant, Androgen-Independent) ...

Japan Prostate cancer Market and Competitive Landscape Highlights – 2016

Japan Prostate cancer Market and Competitive Landscape Highlights – 2016

  • $ 990
  • Industry report
  • April 2016
  • by Fore Pharma

The latest research from Fore Pharma, Japan Prostate cancer Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Prostate cancer pipeline products, Prostate cance ...

US Prostate cancer Market and Competitive Landscape Highlights – 2016

US Prostate cancer Market and Competitive Landscape Highlights – 2016

  • $ 990
  • Industry report
  • April 2016
  • by Fore Pharma

The latest research from Fore Pharma, US Prostate cancer Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Prostate cancer pipeline products, Prostate cancer epidemiology, ...

About 5 800 reports for Prostate Cancer

Download Unlimited Documents from Trusted Public Sources

Therapy Market and Prostate Cancer Statistics in the US

  • March 2015
    104 pages
  • Therapy  

    Hormone  

    Prostate Cancer  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.